跳至主要内容
临床试验/ACTRN12622000020785
ACTRN12622000020785进行中(未招募)未知

QoVAX SET Statewide Long-term COVID-19 Study in adults aged 18 years and older living in Queensland, Australia.

Metro North Hospital and Health Service0 个研究点目标入组 7,446 人开始时间: 2022年1月11日最近更新:
适应症

试验速览

阶段
未知
状态
进行中(未招募)
入组人数
7,446

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • People who reside in Queensland who:
  • 1. are 18 years of age or older,
  • 2. have received any of the Pfizer (BNT162b2), Moderna (MRNA-1273) or AstraChAdOx1 or Novavax COVID19 vaccines, the last of which was received between one and three months prior to giving consent OR have not received any COVID-19 vaccines

排除标准

  • People who:
  • 1. are unable or decline to give informed consent.
  • 2. do not read well enough the English or translated version of the participant information and consent form, and give informed consent, may be excluded if there is no interpreter available to assist and ensure the individual is properly informed and understands what is involved in participation.
  • 3. do not have access to a smart phone or computer to read the participant information and complete the consent form and fill the questionnaire.
  • 4. People who are unable or unwilling to reach a pathology collection centre to donate samples and/or have a contraindication to venepuncture will be excluded from the specimen subset.

研究者

相似试验